From: Evaluation of adverse effects of chemotherapy regimens of 5-fluoropyrimidines derivatives and their association with DPYD polymorphisms in colorectal cancer patients
Polymorphism
Heterozygous
Homozygote
Absence of polymorphism
Total
IVS 14 + 1 G > A
4 (5.5%)
0
69 (94.5%)
73 (100%)
2846 A > T
2194 G > A